Summary & Overview
HCPCS Level II J1980: Injection, Hyoscyamine Sulfate up to 0.25 mg
HCPCS Level II code J1980 denotes an injectable dose of hyoscyamine sulfate up to 0.25 mg. This medication is used in clinical settings to manage conditions requiring anticholinergic effects, and the HCPCS designation allows standardized reporting for administration of the injectable product. Nationally, accurate coding of injectable drugs supports claims processing, billing transparency, and utilization tracking for payers and providers.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical context and service setting, an outline of common payers' coverage considerations, and benchmark-oriented content. The publication also summarizes relevant billing nuances, reporting practices, and common modifiers used with injectable drug administration where applicable.
This article provides practical reference material for billing staff, revenue cycle teams, and compliance officers seeking clear, national-level guidance on identifying and reporting HCPCS Level II code J1980. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code J1980 represents an injectable formulation of hyoscyamine sulfate, dosed up to 0.25 mg per administration. This code is used to report the provision of the medication when delivered by injection.
Service Type: Medication injection
Typical Site of Service: Outpatient clinic, physician office, or other ambulatory setting where injectable medications are administered
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting to an emergency department or outpatient clinic with acute abdominal cramping, intestinal spasm, or symptomatic bladder spasm where symptomatic anticholinergic relief is indicated. The patient may have a diagnosis such as gastrointestinal cramping, irritable bowel syndrome with predominant cramping, or postoperative bladder spasms. After assessment by a physician or advanced practice clinician (for example, a gastroenterologist, emergency medicine physician, or urologist), the decision is made to administer parenteral antispasmodic therapy.
The clinical workflow: the clinician documents the indication, reviews allergies and contraindications, obtains informed consent for an injectable anticholinergic, and orders J1980 (hyoscyamine sulfate injection, up to 0.25 mg). A nurse or licensed clinician prepares and administers the medication via intramuscular or subcutaneous route per facility protocol, monitors the patient for therapeutic effect and anticholinergic adverse effects (dry mouth, blurred vision, tachycardia), and documents lot number, dose, route, time, and site of administration. Billing is submitted using J1980 with an appropriate modifier if required by payer rules.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |